Bazzzigar Posted - 10 hours ago

$SMMT

DaBullRunner Posted - 13 hours ago

$NIVF and guess who got in $SMMT BEFORE the euphoria👇 Now I’m getting in NIVF before the euphoria

jrrt1978 Posted - 13 hours ago

$NIVF looking for 8-20x from here which would impute an MC of 50M to 125m in a squeeze situation $SMMT

Swingtrader123456789 Posted - 13 hours ago

$SMMT ceo only owns 550 million shares.... 11/15 billion of his fortune is with this company. Already approved drug in China. 11month versus 5.5 months from current standard of care for small cell lung cancer Offering just done for 230 mil where 80 Mil of it came from insiders at 22.7$ per share.

DavidScrypTo Posted - 14 hours ago

$TNXP $JAGX $SMMT $ADTX

dustinthebrain Posted - 14 hours ago

$SMMT proof this thing is going to explode any day now

___dog___ Posted - 15 hours ago

$SMMT 10 is coming

Jahlisgo Posted - 15 hours ago

$SMMT is this why its down - https://finance.yahoo.com/news/summit-therapeutics-smmt-hurt-bronte-132726043.html cited the stock as deeply junky. They seem butthurt that their short position did not go so well lol.

liquidmetal Posted - 16 hours ago

$SMMT smells like nervanah!

BioSensai Posted - 18 hours ago

$NVCT This smells JUSt like $smmt

BioSensai Posted - 18 hours ago

$NVCT Insiders loading up all the way into JPM in April. Expect rapid price recovery here folks. This is $smmt at $1

TruthBroker2 Posted - 19 hours ago

$SMMT Up

mingdalee1982 Posted - 1 day ago

@tradingjunk321 They're apples and oranges. $SMMT will failure and $CRVS gets win finally. Duggan is just business man, he does not understand the science behind drug.

ElectricJ Posted - 1 day ago

$MSTR is just getting warmed up. Nav is still quite low, and once FASB rules kick in the $BTC.X gains are going to be massive. Further, they are only #20 among YTD gainers for 2024. 746% is massive but $SMMT & $SMR are among those that have done better. Plenty of room for Microstrategy to continue these gains.

TruthBroker2 Posted - 1 day ago

$SMMT Team $SMMT

Sexychart Posted - 1 day ago

$TNXP $JAGX $SMMT $ADTX

BigBeardTrader Posted - 1 day ago

$SMMT https://wsw.com/webcast/jeff315/9926.hk/1912092

Bazzzigar Posted - 1 day ago

$SMMT

Bazzzigar Posted - 1 day ago

$SMMT

db59 Posted - 1 day ago

$SMMT Summit is a long-term investment. Druckenmiller recommends investing 12–18 months in the future; and, Buffet recommends that you should be able to invest, turn off internet access, and return 4-5 years later and still be happy with your decision. That’s SMMT. Buy now. Harvest in the future. Even so, next year will be filled with many catalysts.

BigBeardTrader Posted - 1 day ago

$SMMT There she goes

BigBeardTrader Posted - 1 day ago

$SMMT rejecting the 1hour 30 day moving average and the 19.45 resistance. Hopefully we break through and close above them.

Iman133 Posted - 1 day ago

It reminds me $SMMT

jheerdink Posted - 1 day ago

$LTRN "The initiation of patient dosing in Japan is a significant milestone for the HARMONIC™ trial and our mission to develop LP-300 as a potential new treatment option for never-smoker NSCLC patients," said Panna Sharma, President and CEO of Lantern Pharma. $SMMT https://finance.yahoo.com/news/lantern-pharma-announces-first-patient-130000068.html

GPS_OS_21_vs_SOC_5 Posted - 1 day ago

$SLS Spidey Senses - Partnership / Buyout News While the market often misses major value $SMMT $DRUG $IMGN $CPXX and most* Dumb As F___ Naive Herd Retail don't appreciate the Value of -- 100% Complete Remission Rates for Optimally Dosed ASXL1+, End Stage Dying AML Patients --- Big Pharma Gets It. They Understand the Value.

BioSensai Posted - 1 day ago

$NVCT 2025 is FILLEd with catalysts. Tutes know the value that NXP-800 and -900 hold, specifically $smmt related TAM for -900 and will not wait for data to buy in. Expect rapid price recovery in coming weeks Q1: Efficacy data on NXP-800 75mg dose on Cholangiocarcinoma via Mayo clinic Q1: NXP-900 dose escalation. this one is not just safety, but also looking well past what would be considered therapeutic dose for solid tumors Q1: JPM conference Q2: NXP-800 75mg ovarian efficacy data Q3/Q4: NXP-900 efficacy data begins to roll in both combo and single agent therapy

Sexychart Posted - 1 day ago

$ADTX 📈💥🥰 $JAGX $TNXP $SMMT

Jahlisgo Posted - 1 day ago

$SMMT damn this stock is resilient

BigBeardTrader Posted - 1 day ago

$SMMT I should add that this was the CFO of Akeso at a conference just now.

BigBeardTrader Posted - 1 day ago

$SMMT CFO just said " other people might be doing deals, but were years ahead of all of them"